CENTRAL TRUST Co - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.

Quarter-by-quarter ownership
CENTRAL TRUST Co ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2018$14,000
+16.7%
228
-14.9%
0.00%0.0%
Q1 2018$12,000
-61.3%
268
-65.1%
0.00%
-50.0%
Q4 2017$31,0000.0%7680.0%0.00%0.0%
Q3 2017$31,000
-57.5%
768
-54.9%
0.00%
-60.0%
Q2 2017$73,000
+25.9%
1,704
-8.1%
0.01%
+25.0%
Q1 2017$58,000
+23.4%
1,8550.0%0.00%
+33.3%
Q4 2016$47,000
-13.0%
1,855
-15.1%
0.00%
-25.0%
Q3 2016$54,000
+134.8%
2,184
+94.1%
0.00%
+100.0%
Q2 2016$23,0001,1250.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders